Plus Therapeutics, Inc. Expands ReSPECT™ Clinical Trial to MD Anderson Cancer Center

Press/Media: Press / Media

Period	Dec 9 2020

Media coverage

Title Plus Therapeutics, Inc. Expands ReSPECT™ Clinical Trial to MD Anderson Cancer Center
Media name/outlet Impact Financial News
Country United Kingdom
Date 12/9/20
Persons Andrew Brenner

Title	Plus Therapeutics, Inc. Expands ReSPECT™ Clinical Trial to MD Anderson Cancer Center
Media name/outlet	Impact Financial News
Country	United Kingdom
Date	12/9/20
Persons	Andrew Brenner